Anakinra Versus Placebo Double Blind Randomized Controlled Trial for the Treatment of Acute MyocarditIS

Trial Profile

Anakinra Versus Placebo Double Blind Randomized Controlled Trial for the Treatment of Acute MyocarditIS

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs Anakinra (Primary)
  • Indications Myocarditis
  • Focus Therapeutic Use
  • Acronyms ARAMIS
  • Most Recent Events

    • 13 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 14 May 2017 Planned End Date changed from 1 Mar 2021 to 15 Jun 2021.
    • 14 May 2017 Planned primary completion date changed from 1 Mar 2020 to 15 Jun 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top